Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01146899 · ClinicalTrials.gov registry record · NA

FluAlert: Influenza Vaccine Alerts for Providers in the Electronic Health Record

A NA study, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
6,145
Enrollment target

NCT01146899: Completed NA study, sponsored by Columbia University.

NCT01146899 is a NA study that has completed, run by Columbia University. The registered enrollment target is 6,145 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (338% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01146899, a NA study, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
6,145 participants
Enrollment target

Study Summary

Childhood influenza coverage rates are far below rates for the other childhood vaccinations. Increasing influenza vaccine coverage rates is important not only for the health of the child, but for that of the child's household and community. Yet,influenza vaccine delivery rates at pediatric clinics are low, even when the vaccine is available. The proposed project will take advantage of existing health information technology to tailor, implement and evaluate influenza vaccine alerts in the electronic health record (EHR) for pediatric providers to help improve health care decision making.

Interventions

  • OTHER Provider Alert

Trial Details

FieldValue
Enrollment Target 6,145 participants
Start Date 2009-12
Est. Completion 2013-06
Phase NA
Columbia University

958 total trials

What the finished NCT01146899 record still lists

NCT01146899 is an interventional study that assigns participants to a tested intervention. Its 6,145 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (338% higher).

The record links to 0 conditions, and to 1 intervention - of which Provider Alert is the first listed.

NCT01146899 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01146899 about?

NCT01146899 is a clinical study titled "FluAlert: Influenza Vaccine Alerts for Providers in the Electronic Health Record". Childhood influenza coverage rates are far below rates for the other childhood vaccinations. Increasing influenza vaccine coverage rates is important not only for the health of the child, but for that of the child's household and community. Yet,influenza vaccine delivery rates at pediatric clinics a...

What is the current status of trial NCT01146899?

This trial is currently completed. It is a NA study. The enrollment target is 6,145 participants. The study started on 2009-12. Estimated completion is 2013-06.

What interventions are being tested in trial NCT01146899?

The interventions under investigation include: Provider Alert (OTHER).

Who is sponsoring clinical trial NCT01146899?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01146899's enrollment target sits among peer trials

6,145 22nd of 2000 higher than 1,979 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04774159 · 6,150 participants · Phase 3

    Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

  • NCT06304168 · 6,150 participants

    Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study

  • NCT07049861 · 6,200 participants · NA

    Advancing Biopsychosocial Care Training Initiative

  • NCT07166861 · 6,080 participants · NA

    Annual Wellness Visits vs GRACE-augmented Annual Wellness Visits For Older Adults With High Needs - Phase 2

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01146899, the US trial registry maintained by the National Library of Medicine. NCT01146899 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.